BioSpace News Archive

Business

Stanford Medical Pioneers Form Katexco Pharmaceuticals to Develop Innovative CBD Therapies to Treat Inflammatory Diseases

Katexco Developing First Drug to Exploit Brain Receptor to Treat Crohn’s Disease, Rheumatoid Arthritis, Multiple Sclerosis and More

October 24, 2018
·
4 min read
Business

Compugen Third Quarter 2018 Conference Call Scheduled for Wednesday, November 7, 2018 at 8:30 AM ET

Company will release its third quarter 2018 financial results on Wednesday, November 7, 2018 before the U.S. financial markets open.

October 24, 2018
·
1 min read
Drug Development

Novaliq Announces Positive Topline Results for Its SEECASE Phase 2 Trial of NOV03 for the Treatment of Patients with Dry Eye Disease

The SEECASE trial met its prespecified primary endpoint for both treatment schedules at 8 weeks

October 24, 2018
·
5 min read
Drug Development

Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint

The safety and tolerability observed in the trial were consistent with previously published data on darolutamide.

October 24, 2018
·
5 min read
Business

Orexo Appoints Joseph DeFeo as New CFO

Orexo AB announces today that the company appoints Joseph DeFeo as the company’s new Chief Financial Officer (CFO) from November 1, 2018.

October 24, 2018
·
2 min read
Drug Development

BiondVax’s Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season’s Enrollment of 4,098 Participants

Phase 3 trial of the M-001 universal flu vaccine candidate.

October 24, 2018
·
4 min read
FDA

Agena And DaRui Biotechnology Announce China FDA Clearance Of MassARRAY Technology For Diagnostic Use In China

Commercially branded in China as DR MassARRAY by DaRui, the approval of the MALDI-TOF based system for targeted genetic analysis is the successful culmination of the commercial partnership that was initiated in 2016 between the two companies.

October 24, 2018
·
2 min read
Deals

Pyramidion Technology Group, Inc. (“PYTG”) Announces Closing Its Acquisition With Established CBD Company NxGen Brands, LLC

PYTG officially owns NxGen operations, brands, marketplace and is currently now a subsidiary of Pyramidion Technology Group, Inc.

October 24, 2018
·
3 min read
Pharm Country

Tris Pharma Presents Results from Two Clinical Studies on Dyanavel® XR at the Largest Annual Meeting of Child and Adolescent Psychiatrists

65th Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) taking place in Seattle, Washington, October 22 to 27, 2018.

October 24, 2018
·
5 min read
Business

BIONIK Laboratories Announces Purchase Agreement from Clinique Les Trois Soleils for InMotion Arm™ Robotic System

Leading French rehabilitation facility adds fourth InMotion robotic system to provide enhanced inpatient neurorehabilitation

October 24, 2018
·
5 min read